維視圖像 MVIS 深 滬
已收盤 02-06 16:00:00 美东时间
0.7688
+0.101
+15.09%
華盛通- 最 高0.776
- 今 開0.6933
- 成交量 508.20万股
- 最 低 0.6844
- 昨 收 0.668
- 總市值 2.35亿
- 52周最高 1.93
- 市盈率 靜 --
- 換手率 1.66%
- 52周最低 0.6505
- 委 比 -77.17%
- 總股本 3.05亿
- 歷史最高 28.00
- 量 比 0.64
- 振 幅 13.71%
- 歷史最低 0.153
- 每 手 1
- 風險率 0.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Microvision übernimmt Lidar-Sensor-Geschäft von Luminar für 33 Millionen Dollar
Microvision übernimmt Lidar-Sensor-Geschäft von Luminar für 33 Millionen Dollar MicroVision Inc. hat bekannt gegeben, dass das Unternehmen bestimmte Vermögenswerte im Zusammenhang mit dem Lidar-Sensor-Geschäft von Luminar Technologies, Inc. übernommen hat. Der Kaufpreis betrug 33 Millionen US-Dollar
02-04 19:04
MicroVision Acquires Luminar Lidar Sensor Assets for $33 Million
MicroVision Acquires Luminar Lidar Sensor Assets for $33 Million MicroVision Inc. has completed the acquisition of certain assets related to Luminar Technologies’ lidar sensor business. The transaction closed on February 3, 2026, with MicroVision paying $33 million in cash to Luminar. Disclaimer: Th
02-04 19:04
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
D. Boral Capital Maintains Buy on Microvision, Maintains $3 Price Target
D. Boral Capital analyst Jason Kolbert maintains Microvision (NASDAQ:MVIS) with a Buy and maintains $3 price target.
01-27 23:51
MicroVision Signs Agreement To Acquire Certain Assets From Luminar Technologies For $33M In Cash
MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced that it had entered into an agreement to acquire certain assets from Luminar
01-27 22:06
MicroVision Receives Nasdaq Deficiency Notice on Bid Price
The latest update is out from Microvision ( ($MVIS) ). On January 12, 2026, Mic...
01-17 06:30
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
MicroVision CFO Anubhav Verma resigns
MicroVision (MVIS) said on November 17, 2025, Anubhav Verma, the Chief Financial Officer of the company, resigned from his position, effective December 31, 2025. The company’s Board of Directors has a...
2025-11-22 06:27
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
2025-11-13 09:58
What's Going On With MicroVision Shares Wednesday?
MicroVision shares are trading lower Wednesday after the company reported mixed third quarter financial results on Tuesday after the market closed.
2025-11-13 05:18
